Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes - PubMed
Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes
Gregory T Crimmins et al. PLoS Pathog. 2012.
Abstract
A highly conserved virulence plasmid encoding a type III secretion system is shared by the three Yersinia species most pathogenic for mammals. Although factors encoded on this plasmid enhance the ability of Yersinia to thrive in their mammalian hosts, the loss of this virulence plasmid does not eliminate growth or survival in host organs. Most notably, yields of viable plasmid-deficient Yersinia pseudotuberculosis (Yptb) are indistinguishable from wild-type Yptb within mesenteric lymph nodes. To identify chromosomal virulence factors that allow for plasmid-independent survival during systemic infection of mice, we generated transposon insertions in plasmid-deficient Yptb, and screened a library having over 20,000 sequence-identified insertions. Among the previously uncharacterized loci, insertions in mrtAB, an operon encoding an ABC family transporter, had the most profound phenotype in a plasmid-deficient background. The absence of MrtAB, however, had no effect on growth in the liver and spleen of a wild type strain having an intact virulence plasmid, but caused a severe defect in colonization of the mesenteric lymph nodes. Although this result is consistent with lack of expression of the type III secretion system by Wt Yptb in the mesenteric lymph nodes, a reporter for YopE indicated that expression of the system was robust. We demonstrate that the ATPase activity of MrtB is required for growth in mice, indicating that transport activity is required for virulence. Indeed, MrtAB appears to function as an efflux pump, as the ATPase activity enhances resistance to ethidium bromide while increasing sensitivity to pyocyanin, consistent with export across the inner membrane.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

A) Growth within the spleen (blue diamond) and liver (red square) after IV inoculation of Yptb(P−) in C57BL/6 mice. 1×105 Yptb(P−) were IV inoculated, organs were collected 3 days post-infection, and bacterial numbers were determined by colony forming units (CFU) per organ. N = 3–6 mice, mean CFU is plotted, ± standard deviation. B) Average number of unique transposon insertion clones in the Input library, and per organ over 6 days post IV infection, +/− standard deviation, N = 3.

A) Number of genes that were mutated in each input library, and the number of genes mutated in both libraries. Red = library #1, Blue = library #2. B) Quality control of 2 biological replicates (BR) of the Input Library #2, sequenced separately. Gene number is on the X axis (Yptb has 4250 genes), and log2(ratio of each gene in BR 1/BR 2) is on the Y axis. Dashed line = 1 standard deviation, solid line = 2 standard deviations C) Histogram of 1977 genes mutated in both library #1 and library #2, X axis = log2(Average ratio of Liver Output/Input), Y axis = number of genes that have a threshold X value. The X axis extends to include values for all genes.

A) In frame deletion of mrtAB in Yptb(P−) recapitulates the data from the screen. Mice were inoculated IV with 1×105 bacteria, organs were collected 3 days post-infection, and bacterial number was determined by colony forming units (CFU) per organ. N = 4–6 mice. B) Deletion of mrtAB does not alter growth at 37° in 2XYT broth culture. Data are mean of 3 replicates, error bars = ± standard deviation. C) Rescue of Yptb(P−) ΔmrtAB in trans with pmrtAB. Mice were injected IV with 1×105 Yptb (P−)/Vector, Yptb (P−)ΔmrtAB/Vector, or Yptb (P−) ΔmrtAB/pmrtAB, spleens were collected 3 days post-infection and analyzed as in A. N = 5 mice. D) Growth curve of Yptb (P−) and Yptb (P−) ΔmrtAB in liver and spleen over 3 days. Mice were injected IV with 1×105 Yptb (P−) and Yptb (P−) ΔmrtAB, organs were collected between 4 hours and 3 days post-infection, and analyzed as in A. N = 3 mice, +/− standard deviation. *Statistical significance (P*) in Figure 3 was determined by nonparametric Mann–Whitney test.

A) Growth of Yptb (P+) in spleen and liver is unaffected by the absence of mrtAB. Mice were inoculated IV with 103 Yptb (P+) derivatives, organs were collected 3 days post-infection, and bacterial number was determined by colony forming units (CFU) per organ. N = 4 or 6. B) Yptb (P+) requires MrtAB for optimal colonization of mesenteric lymph nodes. Mice were orally inoculated with 2×109 Yptb(P+) or Yptb(P+)ΔmrtAB, organs were collected at 1 day post-infection, and analyzed as in A. The dashed line indicates the limit of detection. N = 10 mice. C) Defect in MLN colonization caused by absence of MrtAB is rescued in trans by intact mrtAB. Mice were orally inoculated with 2×109 Yptb(P+)/vector, Yptb(P+)ΔmrtAB/vector, or Yptb(P+)ΔmrtAB/pmrtAB, organs were collected 1 day post-infection and analyzed as in A. N = 8 or 9 mice. D) The defect in MLN colonization caused by the absence of MrtAB can be recapitulated after intraperitoneal inoculation. IP inoculation was performed with 2×105 Yptb(P+)or Yptb(P+)ΔmrtAB Yptb. Organs were collected 1 day post-infection, and analyzed as in A. N = 4 mice. *Statistical significance was determined by nonparametric Mann–Whitney test.

A) Mice were infected IV with 1×105 Yptb(P−)/vector, Yptb(P−)ΔmrtAB/vector, Yptb(P−)ΔmrtAB/pmrtA + mrtB +-flag complementation vector, or Yptb(P−)ΔmrtAB/pmrtA + mrtB*-flag complementation vector with *K380A mutation in MrtB. Spleens were collected 3 days post infection, and bacterial number was determined by colony forming units (CFU) per organ. N = 6 or 8 mice. B) Bacteria were grown in vitro to examine the effect of disrupting the MrtB-FLAG Walker A box on MrtB-FLAG expression. Yptb(P−) ΔmrtAB/vector (Lane 1 = 26°C, Lane 2 = 37°C), Yptb(P−)ΔmrtAB/pmrtA + mrtB + -flag (Lane 3 = 26°C, Lane 4 = 37°C), or Yptb(P−)ΔmrtAB/pmrtA + mrtB*-flag (*K380A) (Lane 6 = 26°C, Lane 7 = 37°C), were grown in LB in vitro at 26° or 37°. Blots were stripped and re-probed with S2 antibody for a loading control. *P: Statistical significance was determined by nonparametric Mann–Whitney test.

Mice were orally inoculated with 2×109 (MLN) or injected IV with 103 (Spleen) bacteria to approximately synchronize the infections, organs were collected 2 days post-inoculation, and tissue sections were stained for DNA (Hoechst). Displayed are representative images of Yptb(P+)-GFP/YopE-mCherry micro-colonies in the spleen (A) or MLN (B). (Median mCherry fluorescence intensity)/(median GFP fluorescence intensity) for Yptb(P+)/GFP/YopE-mCherry micro-colonies, or Yptb(P+)/GFP micro-colonies in the spleens and MLNs, is graphed in C. Each symbol in C represents a different focus of infection. N = 3 (GFP control) or N = 7–8 (Reporter). D) Spleens from mice infected IV with 1×103 GFP-Wt Yptb, or E) MLN from mice orally inoculated with 2×109 GFP-Wt Yptb, were isolated 2 days post-infection, and tissue sections were stained for neutrophils (Ly6G) and DNA (Hoechst). D and E are representative images.

A) MrtAB deficient Yptb(P+) exhibit a modest decrease on MLN colonization at 4 days post-infection. Mice were orally inoculated with 2×109 Yptb(P+) or Yptb(P+)ΔmrtAB, and the small intestines, MLNs, and PPs were collected at 4 days post-infection, and bacterial number was determined by colony forming units (CFU) per organ. N = 4 mice (PP) or 9 mice (SI and MLN). *P: Statistical significance was determined by nonparametric Mann–Whitney test. B) Yptb(P+) and Yptb(P+)ΔmrtAB display equal early colonization of the spleen following oral infection. Mice were orally inoculated with 2×109 Yptb(P+) or Yptb(P+)ΔmrtAB, and the small intestines and spleens were collected at 2 days post-infection, and analyzed as in A. N = 5 mice. C) Yptb(P+) and Yptb(P+)ΔmrtAB are equally lethal following oral infection with 109 bacteria. Mice were orally inoculated with 109 Yptb(P+) or Yptb(P+)ΔmrtAB, and the survival of infected mice was monitored over 12 days. N = 8 mice.
Similar articles
-
Bliska JB, Brodsky IE, Mecsas J. Bliska JB, et al. EcoSal Plus. 2021 Dec 15;9(2):eESP00142021. doi: 10.1128/ecosalplus.ESP-0014-2021. Epub 2021 Oct 27. EcoSal Plus. 2021. PMID: 34910573 Free PMC article. Review.
-
IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
Miller HK, Kwuan L, Schwiesow L, Bernick DL, Mettert E, Ramirez HA, Ragle JM, Chan PP, Kiley PJ, Lowe TM, Auerbuch V. Miller HK, et al. PLoS Pathog. 2014 Jun 12;10(6):e1004194. doi: 10.1371/journal.ppat.1004194. eCollection 2014 Jun. PLoS Pathog. 2014. PMID: 24945271 Free PMC article.
-
Balada-Llasat JM, Mecsas J. Balada-Llasat JM, et al. PLoS Pathog. 2006 Sep;2(9):e86. doi: 10.1371/journal.ppat.0020086. PLoS Pathog. 2006. PMID: 16948531 Free PMC article.
-
McPhee JB, Mena P, Zhang Y, Bliska JB. McPhee JB, et al. Infect Immun. 2012 Jul;80(7):2519-27. doi: 10.1128/IAI.06364-11. Epub 2012 Apr 30. Infect Immun. 2012. PMID: 22547545 Free PMC article.
-
[PLASMID-ASSOCIATED VIRULENCE OF YERSINIA PSEUDOTUBERCULOSIS AND INFECTIOUS PROCESS].
Somova LM, Shubin FN, Drobot EI, Plekhova NG, Lyapun IN. Somova LM, et al. Zh Mikrobiol Epidemiol Immunobiol. 2016 Nov;(6):74-85. Zh Mikrobiol Epidemiol Immunobiol. 2016. PMID: 30695393 Review. Russian.
Cited by
-
Iron-Sulfur Cluster Repair Contributes to Yersinia pseudotuberculosis Survival within Deep Tissues.
Davis KM, Krupp J, Clark S, Isberg RR. Davis KM, et al. Infect Immun. 2019 Sep 19;87(10):e00533-19. doi: 10.1128/IAI.00533-19. Print 2019 Oct. Infect Immun. 2019. PMID: 31331956 Free PMC article.
-
Bliska JB, Brodsky IE, Mecsas J. Bliska JB, et al. EcoSal Plus. 2021 Dec 15;9(2):eESP00142021. doi: 10.1128/ecosalplus.ESP-0014-2021. Epub 2021 Oct 27. EcoSal Plus. 2021. PMID: 34910573 Free PMC article. Review.
-
Bacterial genetics and molecular pathogenesis in the age of high throughput DNA sequencing.
Davey L, Valdivia RH. Davey L, et al. Curr Opin Microbiol. 2020 Apr;54:59-66. doi: 10.1016/j.mib.2020.01.007. Epub 2020 Feb 7. Curr Opin Microbiol. 2020. PMID: 32044689 Free PMC article. Review.
-
Paczosa MK, Silver RJ, McCabe AL, Tai AK, McLeish CH, Lazinski DW, Mecsas J. Paczosa MK, et al. Infect Immun. 2020 Mar 23;88(4):e00034-20. doi: 10.1128/IAI.00034-20. Print 2020 Mar 23. Infect Immun. 2020. PMID: 31988174 Free PMC article.
-
Coregulation of host-adapted metabolism and virulence by pathogenic yersiniae.
Heroven AK, Dersch P. Heroven AK, et al. Front Cell Infect Microbiol. 2014 Oct 20;4:146. doi: 10.3389/fcimb.2014.00146. eCollection 2014. Front Cell Infect Microbiol. 2014. PMID: 25368845 Free PMC article. Review.
References
-
- Wren BW (2003) The yersiniae–a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol 1: 55–64. - PubMed
-
- Smego RA, Frean J, Koornhof HJ (1999) Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis 18: 1–15. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01AI23538/AI/NIAID NIH HHS/United States
- T32AI007422/AI/NIAID NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- F32 AI085706/AI/NIAID NIH HHS/United States
- R56AI23538-24A1/AI/NIAID NIH HHS/United States
- R21 AI076156/AI/NIAID NIH HHS/United States
- AI055976/AI/NIAID NIH HHS/United States
- T32 AI007422/AI/NIAID NIH HHS/United States
- P30 NS047243/NS/NINDS NIH HHS/United States
- AI076156/AI/NIAID NIH HHS/United States
- R56 AI023538/AI/NIAID NIH HHS/United States
- R01 AI023538/AI/NIAID NIH HHS/United States
- R01 AI055976/AI/NIAID NIH HHS/United States
- F32AI085706/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources